Tab. VII.

Persistence (%) with prescribed antimuscarinic therapy for overactive bladder – one year's observation [7, 40]

		Anticholinergics
		Solifenacin	Darifenacin	Tolterodine	Tolterodine	Propiverine	Oxybutynin	Oxybutynin	Trospium	Flavoxate
				IR	ER		IR	ER
Treatment persistence at 3 months	%	58	52	46	47	47	40	44	42	28
Treatment persistence at 12 months		35	17	24	28	27	22	26	26	14